Generic name · Immunology / IL-4/13
Dupilumab J-Code / HCPCS Code
In short
Med-Code's directory has no drug-specific HCPCS code for Dupilumab. It is usually self-administered and billed by NDC through a pharmacy benefit. Where a payer accepts an unclassified code for it in a clinical setting, that code is J3590 (Unclassified biologics), reported with the NDC and quantity.
Reference
- Code
- J3590 — Unclassified biologicsMed-Code curated
- Billing unit
- No defined unit — report the NDC and quantity
- Same code in the directory
- Dupixent
- Pharmacologic class
- Interleukin-4 Receptor alpha AntagonistFrom the FDA listings below
- Labelers
- Sanofi-Aventis U.S. LLC
- J-code category
- Immunology / IL-4/13
FDA-listed products
Finished products whose name and route match this directory entry.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Dupixentdupilumab | Dupilumab 300 mg/2mL | Injection, SolutionSubcutaneous | Sanofi-Aventis U.S. LLC | 0024-5914 |
| Dupixentdupilumab | Dupilumab 300 mg/2mL | Injection, SolutionSubcutaneous | Sanofi-Aventis U.S. LLC | 0024-5915 |
| Dupixentdupilumab | Dupilumab 200 mg/1.14mL | Injection, SolutionSubcutaneous | Sanofi-Aventis U.S. LLC | 0024-5918 |
| Dupixentdupilumab | Dupilumab 200 mg/1.14mL | Injection, SolutionSubcutaneous | Sanofi-Aventis U.S. LLC | 0024-5919 |